Table 2. Methodological quality assessment for inclusion studies.
| Study | Eligibility Criteria | Random Allocation | Allocation Concealment | Baseline Comparability | Blind Participants | Blind Therapist | Blind Assessor | Follow-Up | Intention to Treat Analysis | Between Group Comparisons | Point Measure and Variability | Total PEDro Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Osipov et al. 2019 [67] | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5 |
| Yüksel et al. 2019 [70] | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5 |
| Ambroży et al. 2022 [59] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
| Kudryavtsev et al. 2023 [63] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
| Zhu. 2023 [69] | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5 |
| Osipov et al. 2022 [65] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
| Galimova et al. 2018 [62] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
| Türker & Yüksel. 2020 [68] | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5 |
| Mischenko et al. 2021 [64] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
| Caloglu & Yuksel. 2020 [41] | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5 |
| Avetisyan et al. 2022 [60] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
| Bozdoğan. 2021 [61] | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 6 |
| Osipov et al. 2017 [66] | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5 |